0001823884--12-312022Q335400000354000000034500000332362643450000034500000952500094508249525000952500000862500086250009000009000003450000095250003323626494508243450000095250003450000095250000.130.060.030.080.130.060.030.08P10D0.130.130.060.060.030.030.080.080.20.2false0001823884vtiqu:LoansReceivedFromRelatedPartyMembervtiqu:SponsorsMember2022-09-300001823884vtiqu:LoansReceivedFromRelatedPartyMembervtiqu:SponsorsMember2021-12-310001823884us-gaap:PrivatePlacementMember2022-09-300001823884vtiqu:SponsorsMemberus-gaap:PrivatePlacementMember2021-01-110001823884vtiqu:AnchorInvestorsMemberus-gaap:IPOMember2021-01-110001823884us-gaap:OverAllotmentOptionMember2021-01-110001823884vtiqu:SponsorsMember2022-01-012022-09-300001823884vtiqu:RedeemableWarrantMemberus-gaap:InvestorMember2021-01-112021-01-110001823884us-gaap:CommonStockMember2022-01-012022-09-300001823884us-gaap:WarrantMember2022-01-012022-09-300001823884vtiqu:InitialDirectorNomineesMember2020-09-040001823884vtiqu:PromotersMember2020-08-310001823884us-gaap:CommonClassBMember2022-01-012022-09-300001823884us-gaap:CommonClassAMemberus-gaap:PrivatePlacementMember2022-01-012022-09-300001823884us-gaap:CommonStockMemberus-gaap:IPOMember2021-01-112021-01-110001823884vtiqu:RedeemableWarrantMemberus-gaap:IPOMember2021-01-112021-01-110001823884vtiqu:PrivateWarrantMemberus-gaap:CommonStockMember2022-01-012022-09-300001823884us-gaap:SubsequentEventMember2022-10-280001823884vtiqu:LoansReceivedFromRelatedPartyMembervtiqu:SponsorsMember2022-01-012022-09-3000018238842021-01-112021-01-110001823884us-gaap:SubsequentEventMember2022-10-282022-10-280001823884vtiqu:LoansReceivedFromRelatedPartyMembervtiqu:SponsorsMember2020-08-312020-08-310001823884vtiqu:SponsorsMemberus-gaap:PrivatePlacementMember2022-01-012022-09-300001823884vtiqu:PromotersMember2022-01-012022-09-300001823884vtiqu:RedeemableWarrantMember2022-01-012022-09-300001823884vtiqu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member2022-01-012022-09-300001823884vtiqu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member2022-01-012022-09-300001823884us-gaap:IPOMember2022-01-012022-09-3000018238842021-01-110001823884us-gaap:OverAllotmentOptionMember2021-01-112021-01-110001823884us-gaap:PrivatePlacementMember2022-01-012022-09-300001823884us-gaap:AdditionalPaidInCapitalMember2021-01-012021-06-300001823884us-gaap:CommonClassAMemberus-gaap:IPOMember2022-01-012022-09-300001823884us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-01-012021-06-300001823884us-gaap:RetainedEarningsMember2022-09-300001823884us-gaap:RetainedEarningsMember2022-06-300001823884us-gaap:RetainedEarningsMember2021-12-310001823884us-gaap:RetainedEarningsMember2021-09-300001823884us-gaap:RetainedEarningsMember2021-06-3000018238842021-06-300001823884us-gaap:RetainedEarningsMember2020-12-310001823884us-gaap:AdditionalPaidInCapitalMember2020-12-310001823884vtiqu:RedeemableWarrantMember2022-09-300001823884vtiqu:PrivatePlacementWarrantsMember2022-09-300001823884vtiqu:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001823884vtiqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001823884vtiqu:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001823884vtiqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001823884us-gaap:IPOMember2021-01-110001823884vtiqu:CommonClassaSubjectToRedemptionMember2022-09-300001823884vtiqu:SponsorsMemberus-gaap:PrivatePlacementMember2021-01-112021-01-110001823884us-gaap:IPOMember2021-01-112021-01-110001823884vtiqu:InitialDirectorNomineesMember2020-09-042020-09-040001823884vtiqu:SponsorsMember2020-08-312020-08-310001823884vtiqu:AnchorInvestorsMember2021-01-112021-01-110001823884vtiqu:AnchorInvestorsMembervtiqu:FounderSharesMemberus-gaap:IPOMember2021-01-112021-01-110001823884vtiqu:AnchorInvestorsMemberus-gaap:CapitalUnitClassAMemberus-gaap:IPOMember2021-01-112021-01-110001823884vtiqu:AnchorInvestorsMemberus-gaap:IPOMember2021-01-112021-01-110001823884vtiqu:LoansReceivedFromRelatedPartyMember2021-01-110001823884us-gaap:RetainedEarningsMember2022-07-012022-09-300001823884us-gaap:RetainedEarningsMember2022-01-012022-06-3000018238842022-01-012022-06-300001823884us-gaap:RetainedEarningsMember2021-07-012021-09-300001823884us-gaap:RetainedEarningsMember2021-01-012021-06-3000018238842021-01-012021-06-300001823884vtiqu:AdministrativeSupportAgreementMember2022-07-012022-09-300001823884vtiqu:AdministrativeSupportAgreementMember2022-01-012022-09-300001823884vtiqu:AdministrativeSupportAgreementMember2021-07-012021-09-300001823884vtiqu:AdministrativeSupportAgreementMember2021-01-012021-09-300001823884us-gaap:FairValueInputsLevel3Membervtiqu:PublicWarrantsMember2022-09-300001823884us-gaap:FairValueInputsLevel3Membervtiqu:PrivatePlacementWarrantsMember2022-09-300001823884us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2022-09-300001823884us-gaap:FairValueInputsLevel3Membervtiqu:PublicWarrantsMember2022-06-300001823884us-gaap:FairValueInputsLevel3Membervtiqu:PrivatePlacementWarrantsMember2022-06-300001823884us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2022-06-300001823884us-gaap:FairValueInputsLevel3Membervtiqu:PublicWarrantsMember2021-12-310001823884us-gaap:FairValueInputsLevel3Membervtiqu:PrivatePlacementWarrantsMember2021-12-310001823884us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2021-12-310001823884us-gaap:FairValueInputsLevel3Membervtiqu:PublicWarrantsMember2022-07-012022-09-300001823884us-gaap:FairValueInputsLevel3Membervtiqu:PrivatePlacementWarrantsMember2022-07-012022-09-300001823884us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2022-07-012022-09-300001823884us-gaap:FairValueInputsLevel3Membervtiqu:PublicWarrantsMember2022-01-012022-06-300001823884us-gaap:FairValueInputsLevel3Membervtiqu:PrivatePlacementWarrantsMember2022-01-012022-06-300001823884us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMember2022-01-012022-06-3000018238842021-07-012021-09-300001823884vtiqu:CommonClassaSubjectToRedemptionMember2022-07-012022-09-300001823884vtiqu:CommonClassAndClassBNotSubjectToRedemptionMember2022-07-012022-09-300001823884vtiqu:ClassCommonStockIncludedInUnitsSoldMember2022-07-012022-09-300001823884vtiqu:ClassCommonStockIncludedInPrivatePlacementUnitsMember2022-07-012022-09-300001823884vtiqu:CommonClassaSubjectToRedemptionMember2022-01-012022-09-300001823884vtiqu:CommonClassAndClassBNotSubjectToRedemptionMember2022-01-012022-09-300001823884vtiqu:ClassCommonStockIncludedInUnitsSoldMember2022-01-012022-09-300001823884vtiqu:ClassCommonStockIncludedInPrivatePlacementUnitsMember2022-01-012022-09-300001823884vtiqu:CommonClassaSubjectToRedemptionMember2021-07-012021-09-300001823884vtiqu:CommonClassAndClassBNotSubjectToRedemptionMember2021-07-012021-09-300001823884vtiqu:ClassCommonStockIncludedInUnitsSoldMember2021-07-012021-09-300001823884vtiqu:ClassCommonStockIncludedInPrivatePlacementUnitsMember2021-07-012021-09-300001823884vtiqu:CommonClassaSubjectToRedemptionMember2021-01-012021-09-300001823884vtiqu:CommonClassAndClassBNotSubjectToRedemptionMember2021-01-012021-09-300001823884vtiqu:ClassCommonStockIncludedInUnitsSoldMember2021-01-012021-09-300001823884vtiqu:ClassCommonStockIncludedInPrivatePlacementUnitsMember2021-01-012021-09-300001823884vtiqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Membervtiqu:MeasurementInputFairValueOfUnitsMember2022-09-300001823884vtiqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Membervtiqu:MeasurementInputExpectedTermToInitialBusinessCombinationsMember2022-09-300001823884vtiqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2022-09-300001823884vtiqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMember2022-09-300001823884vtiqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMember2022-09-300001823884vtiqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExercisePriceMember2022-09-300001823884vtiqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Membervtiqu:MeasurementInputFairValueOfUnitsMember2021-12-310001823884vtiqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Membervtiqu:MeasurementInputExpectedTermToInitialBusinessCombinationsMember2021-12-310001823884vtiqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMember2021-12-310001823884vtiqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputPriceVolatilityMember2021-12-310001823884vtiqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedDividendRateMember2021-12-310001823884vtiqu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExercisePriceMember2021-12-3100018238842022-06-300001823884vtiqu:CommonClassaSubjectToRedemptionMember2021-12-310001823884us-gaap:USTreasurySecuritiesMember2022-09-300001823884us-gaap:USTreasurySecuritiesMember2021-12-3100018238842022-07-012022-09-300001823884us-gaap:CommonClassBMemberus-gaap:CommonStockMember2022-09-300001823884us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-09-300001823884vtiqu:ClassCommonStockIncludedInPrivatePlacementUnitsMember2022-09-300001823884us-gaap:CommonClassBMemberus-gaap:CommonStockMember2022-06-300001823884us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-06-300001823884us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-12-310001823884us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-12-310001823884us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-09-300001823884us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-09-300001823884us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-06-300001823884us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-06-300001823884us-gaap:CommonClassBMemberus-gaap:CommonStockMember2020-12-310001823884us-gaap:CommonClassAMemberus-gaap:CommonStockMember2020-12-310001823884vtiqu:CommonClassaNotSubjectToRedemptionMember2022-09-300001823884vtiqu:CommonClassaNotSubjectToRedemptionMember2021-12-310001823884us-gaap:CommonClassBMember2022-09-300001823884us-gaap:CommonClassBMember2021-12-310001823884us-gaap:CommonClassAMember2021-12-310001823884vtiqu:SponsorsMember2020-08-310001823884us-gaap:CommonClassAMember2022-09-300001823884vtiqu:PrivateWarrantMemberus-gaap:PrivatePlacementMember2022-09-300001823884vtiqu:PrivateWarrantMemberus-gaap:CommonClassAMember2022-09-300001823884vtiqu:RedeemableWarrantMemberus-gaap:IPOMember2021-01-110001823884vtiqu:RedeemableWarrantMemberus-gaap:CommonStockMemberus-gaap:IPOMember2021-01-1100018238842021-01-012021-09-3000018238842021-09-3000018238842020-12-310001823884vtiqu:CommonClassaSubjectToRedemptionMember2021-01-012021-12-3100018238842021-01-012021-12-310001823884vtiqu:AdministrativeSupportAgreementMember2022-09-3000018238842022-09-300001823884vtiqu:AdministrativeSupportAgreementMember2021-12-3100018238842021-12-310001823884vtiqu:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOfDollar11.50PerShareMember2022-01-012022-09-300001823884vtiqu:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneFifthOfOneRedeemableWarrantMember2022-01-012022-09-300001823884us-gaap:CommonClassAMember2022-01-012022-09-300001823884us-gaap:CommonClassBMember2022-11-010001823884us-gaap:CommonClassAMember2022-11-0100018238842022-01-012022-09-30xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesvtiqu:itemxbrli:purevtiqu:Yvtiqu:Votevtiqu:D

UNITED STATES

SECURITIES AND EXCHANGE

COMMISSION

Washington, D.C. 20549

FORM 10-Q

(MARK ONE)


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended September 30, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-39855

VECTOIQ ACQUISITION CORP. II

(Exact Name of Registrant as Specified in Its Charter)

Delaware		85-2482699
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

1354 Flagler Drive

Mamaroneck, NY 10543

(Address of principal executive offices) (Zip Code 10543)

(914) 374-1929

(Issuer’s telephone number)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant	VTIQU	The Nasdaq Stock Market LLC
Class A Common Stock, par value $0.0001 per share	VTIQ	The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50	VTIQW	The Nasdaq Stock Market LLC

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of November 1, 2022, there were 35,400,000 shares of Class A common stock, par value $0.0001 per share, and 8,625,000 shares of Class B common stock, par value $0.0001 per share, issued and outstanding.

Table of Contents


		PAGE #
PART I.	FINANCIAL INFORMATION

Item 1.	Financial Statements.

	Condensed Balance Sheet as of September 30, 2022 (unaudited) and December 31, 2021	3

	Condensed Statement of Operations for the nine months and three months ended September 30, 2022, and 2021 (unaudited)	4

	Condensed Statement of Stockholders’ Deficit for the nine months and three months ended September 30, 2022, and 2021 (unaudited)	5

	Condensed Statement of Cash Flows for the nine months ended September 30, 2022, and 2021 (unaudited)	6

	Notes to Condensed Financial Statements (unaudited)	7

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	23

Item 3.	Defaults Upon Senior Securities.	27

Item 4.	Controls and Procedures.	26

PART II.	OTHER INFORMATION	26

Item 6.	Exhibits.	29

	Signatures	30

Table of Contents

VECTOIQ ACQUISITION CORP. II

CONDENSED BALANCE SHEETS


	September 30, 2022		December 31, 2021
	(unaudited)
Assets
Current assets:
Cash	$	96,877	$	733,875
Prepaid expenses		115,914		254,032
Total current assets		212,791		987,907

Non-current assets
Cash and marketable securities held in trust account		346,681,932		345,122,968
Total assets	$	346,894,723	$	346,110,875

Liabilities and stockholders’ deficit
Current liabilities:
Accounts payable	$	—	$	110,656
Accrued expenses		2,080,388		1,816,775
Total current liabilities		2,080,388		1,927,431
Warrant liabilities		849,600		5,948,676
Deferred underwriting fee payable		12,075,000		12,075,000
Total liabilities		15,004,988		19,951,107

Commitments
Class A common stock subject to possible redemption 34,500,000 shares at redemption value at $10 per share		346,286,379		345,000,000

Stockholders’ deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—		—
Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 900,000 issued and outstanding excluding 34,500,000 shares subject to possible redemption		90		90
Class B Common stock, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares issued and outstanding		863		863
Additional paid-in capital				—
Accumulated deficit		(14,397,597)		(18,841,185)
Total stockholders’ deficit		(14,396,644)		(18,840,232)
Total liabilities and stockholders’ deficit	$	346,894,723	$	346,110,875

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

VECTOIQ ACQUISITION CORP. II

CONDENSED STATEMENTS OF OPERATIONS

(unaudited)


	Nine months ended September 30,				Three months ended September 30,
	2022		2021		2022		2021
General and administrative expenses	$	893,736	$	2,610,415	$	287,277	$	741,366
Net loss from operations		(893,736)		(2,610,415)		(287,277)		(741,366)

Other income
Interest earned on investment held in Trust Account		1,868,964		82,283		953,413		15,795
Fair value adjustment to warrant liabilities		5,099,076		4,910,274		708,054		4,166,100
Total other income		6,968,040		4,992,557		1,661,467		4,181,895

Income before income taxes		6,074,304		2,382,142		1,374,190		3,440,529

Income tax expense		344,337		—		189,691		—

Net income	$	5,729,967	$	2,382,142	$	1,184,499	$	3,440,529

Weighted average shares outstanding of Class A redeemable ordinary shares		34,500,000		33,236,264		34,500,000		34,500,000

Basic and diluted net income per share, Class A redeemable ordinary shares	$	0.13	$	0.06	$	0.03	$	0.08

Weighted average shares outstanding of Class A and Class B non-redeemable ordinary shares		9,525,000		9,450,824		9,525,000		9,525,000

Basic and diluted net income per share, Class A and Class B non-redeemable ordinary shares	$	0.13	$	0.06	$	0.03	$	0.08

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

VECTOIQ ACQUISITION CORP. II

CONDENSED STATEMENT OF STOCKHOLDERS’ DEFICIT

Nine Months ended September 30, 2022


							Additional				Total
	Class A Common Stock			Class B Common Stock			Paid-In		Accumulated		Stockholders’
	Shares	Amount		Shares	Amount		Capital		Deficit		Deficit
Balance – January 1, 2022	900,000	$	90	8,625,000	$	863	$	—	$	(18,841,185)	$	(18,840,232)
Net income	—	$	—	—	$	—	$	—		4,545,468		4,545,468
Balance – June 30, 2022	900,000		90	8,625,000		863		—		(14,295,717)		(14,294,764)
Increase in redemption value of shares subject to possible redemption										(1,286,379)		(1,286,379)
Net income	—		—	—		—		—		1,184,499		1,184,499
Balance – September 30, 2022 (unaudited)	900,000	$	90	8,625,000	$	863	$	—	$	(14,397,597)	$	(14,396,644)

Nine Months ended September 30, 2021


							Additional				Total
	Class A Common Stock			Class B Common Stock			Paid-In		Accumulated		Stockholders’
	Shares	Amount		Shares	Amount		Capital		Deficit		Deficit
Balance – January 1, 2021	—	$	—	8,625,000	$	863	$	24,137	$	(1,802)		23,198
Issuance of Class A common stock	900,000		90	—		—		8,999,910		—		9,000,000
Fair value of private placement warrant liability	—		—	—		—		(271,044)		—		(271,044)
Excess fair value over consideration of the anchor investors investment in the sponsor	—		—	—		—		3,946,407		—		3,946,407
Remeasurement of shares subject to redemption	—		—	—		—		(12,699,410)		(20,160,305)		(32,859,715)
Net loss	—		—	—		—				(1,058,387)		(1,058,387)
Balance – June 30, 2021	900,000		90	8,625,000		863		—		(21,220,494)		(21,219,541)
Net loss	—		—	—		—		—		3,440,529		3,440,529
Balance – September 30, 2021 (unaudited)	900,000	$	90	8,625,000	$	863	$	—	$	(17,779,965)	$	(17,779,012)

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

VECTOIQ ACQUISITION CORP. II

CONDENSED STATEMENT OF CASH FLOWS

(unaudited)


	Nine Months ended September 30,
	2022		2021
Cash flows from operating activities:
Net income	$	5,729,967	$	2,382,142
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on investment held in Trust Account		(1,868,964)		(82,283)
Change in fair value of warrant liability		(5,099,076)		(4,910,274)
Offering costs attributable to warrant liability		—		687,798
Changes in assets and liabilities:
(Increase) decrease in prepaid expenses		138,118		(323,232)
Increase (decrease) in accounts payable		(110,656)		8,500
Increase in accrued expenses		263,613		1,535,240
Net cash used in operating activities		(946,998)		(702,109)

Cash Flows from Investing Activities:
Distribution of interest income from trust account		310,000		—
Investment of cash in Trust Account		—		(345,000,000)
Net cash used in investing activities		310,000		(345,000,000)

Cash flows from financing activities:
Repayment of notes payable-related party		—		(83,000)
Proceeds from issuance of Class A units		—		354,000,000
Payments of offering costs associated with initial public offering		—		(7,374,235)
Net cash provided by financing activities:		—		346,542,765

Net increase (decrease) in cash		(636,998)		840,656
Cash, beginning of period		733,875		12,564
Cash, end of period	$	96,877	$	853,220

Supplemental disclosure of noncash operating and financing activities:
Remeasurement of shares subject to redemption	$	1,286,379	$	32,859,715
Excess fair value over consideration of the anchor investors investment in the sponsor	$	—	$	3,946,407
Initial classification of warrant liability	$	—	$	10,301,574
Deferred underwriting fee payable	$	—	$	12,075,000

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

Note 1 — Organization, Business Operations and Liquidity

Organization and General

VectoIQ Acquisition Corp. II (the “Company”) was incorporated in Delaware on August 10, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses (the “Business Combination”). Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus its search on the industrial technology, transportation and smart mobility industries, which the Company believes will provide it with access to attractive business combination opportunities. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

As of September 30, 2022, the Company had not commenced any operations. All activity for the period from August 10, 2020 (inception) through September 30, 2022, relates to the Company’s formation, the Initial Public Offering (as defined below) and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering.

The registration statement for the Company’s Initial Public Offering was declared effective on January 6, 2021. On January 11, 2021, the Company consummated the initial public offering (the “Initial Public Offering”) of 34,500,000 units (the “Units” and, with respect to the class A common stock included in the Units sold, the “Public Shares”), which included the exercise in full by the underwriters of their overallotment option in the amount of 4,500,000 Units, at $10 per unit, generating gross proceeds of $345,000,000. See Note 3.

The Company’s sponsor is VectoIQ Holdings II, LLC, a Delaware limited liability company (the “Sponsor”). Simultaneously with the closing of the IPO, the Company consummated the sale, in a private placement, of 900,000 units (each, a “Private Placement Unit” and collectively, the “Private Placement Units”) to the Sponsor at a price of $10.00 per Private Placement Unit, generating total proceeds of $9,000,000. See Note 4.

Two qualified institutional accredited investors that are not affiliated with the Company, the Sponsor, the Company’s directors or any member of the Company’s management (“Anchor Investors”) each expressed to the Company an interest in purchasing an aggregate of 5,985,000 units sold in the IPO, at the offering price of $10.00, for an aggregate of $59,850,000 of units offered. In addition to the investment in the IPO, the Anchor Investors purchased membership units in the Sponsor that entitled them to an economic right in a total of 204,744 Class A Units and 597,871 Founders’ shares.

The Company estimated the aggregate fair value of the economic right to be $6,112,963. The excess of the economic right over the consideration paid by the Anchor Investors amounted to $4,064,692 of which the Company allocated $118,285 to the Public Warrants, as defined below (see Note 3), which is included in accumulated deficit in accordance with Accounting Standards Codification (“ASC”) 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A-”Expenses of Offering”.

Transaction costs amounted to $19,570,579, consisting of $6,900,000 in cash underwriting fees, $12,075,000 of deferred underwriting fees, and $595,579 other offering costs. Transactions costs amounting to $569,513 were allocated to the warrant liability and are recorded in general and administrative expenses in the Statement of Operations for the year ended December 31, 2021, with the remainder or $19,001,066, allocated to the Class A common shares sold in the Initial Public Offering. In addition, as of January 11, 2021, cash of $2,075,000 was held outside of the Trust Account (as defined below) and was available for the payment of offering costs and for working capital purposes.

On January 11, 2021, $345,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”). Management agreed that an amount equal to $10.00 per Unit sold in the Initial Public Offering would be held in a trust account (“Trust Account”), located in the United States at Morgan Stanley with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

completion of a Business Combination and (ii) the distribution of the Trust Account as described below. Unless and until the Company completes its initial Business Combination, no funds held in the Trust Account will be available for its use, except the withdrawal of interest earned to fund its working capital requirements (subject to a limit of $250,000 per year) and/or to pay taxes.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Units, although substantially all of the net proceeds will be held in trust until applied toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete its initial Business Combinations with one or more target businesses having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding taxes payable on income earned on the Trust Account and Delaware franchise tax) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”).

The Company will provide its holders of the outstanding shares of its Class A common stock, par value $0.0001, sold in the Initial Public Offering (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares (as defined below in Note 3) upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the Public Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if a stockholder vote is held to approve such transaction, only if a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transactions is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem its Public Shares without voting and, if it does vote, irrespective of whether it votes for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the initial stockholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the initial stockholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination or any amendment to the provisions of the Company’s Amended and Restated Certificate of Incorporation relating to its pre-initial business combination activity and related stockholders’ rights.

Notwithstanding the foregoing, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Class A common stock sold in the Initial Public Offering, without the prior consent of the Company.

The Company’s Sponsor, officers and directors (the “initial stockholders”) have agreed not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their shares of Class A common stock in conjunction with any such amendment.

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

Initial Business Combination

If the Company is unable to complete a Business Combination within 24 months from the closing of the Proposed Public Offering (or 27 months from the closing of the Initial Public Offering if the Company has executed a letter of intent, agreement in principle or definitive agreement for an initial Business Combination within 24 months from the closing of the Initial Public Offering) (as applicable, the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (less up to $100,000 of interest to pay dissolution expenses, which interest shall be net of taxes payable by the Company), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject t to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

The initial stockholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial stockholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account (or potentially less in certain circumstances). In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business execute agreements (other than the independent registered public accountant) with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Liquidity and Capital Resources

As of September 30, 2022, the Company had cash of approximately $97,000 held outside of the Trust Account and available for working capital purposes.

If the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate our business prior to a Business Combination. Moreover, the Company may need to obtain additional financing either to complete a Business Combination or because the Company becomes obligated to redeem a significant number of public shares upon consummation of a Business Combination, in which case the Company may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, the Company would only complete such financing simultaneously with the completion of a Business Combination. If the Company is unable to complete a Business Combination because it does not have sufficient funds available, the Company will be forced to cease operations and liquidate the Trust Account. In addition, following a Business Combination, if cash on hand is insufficient, the Company may need to obtain additional financing in order to meet its obligations.

In connection with the Company’s assessment of going concern considerations in accordance with ASC Topic 205-40, “Presentation of Financial Statements – Going Concern”, the Company has until January 11, 2023, to consummate a Business Combination. If a Business Combination is not consummated by this date and an extension not requested by the Sponsor, there will be a mandatory liquidation and subsequent dissolution of the Company. Although the Company intends to consummate a Business Combination on or before January 11, 2023, it is uncertain that the Company will be able to consummate a Business Combination by this time. Management has determined that the mandatory liquidation, should a Business Combination not occur, and an extension is not requested by the Sponsor, and potential

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. The Company’s plan is to complete a business combination or obtain an extension on or prior to January 11, 2023, however it is uncertain that the Company will be able to consummate a Business Combination or obtain an extension by this time. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after January 11, 2023.

Risks and Uncertainties

Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might results from the outcome of this uncertainty.

Note 2 — Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on April 15, 2022. The interim results for the nine and three months ended September 30, 2022, are not necessarily indicative of the results to be expected for the year ending December 31, 2022, or for any future periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022, and December 31, 2021.

Marketable Securities Held in Trust Account

The Company classifies its U.S. Treasury securities as held-to-maturity in accordance with ASC Topic 320 “Investments — Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet. Fair value of these marketable securities amounted to $346,667,077 and $345,102,999 as of September 30, 2022, and December 31, 2021, respectively. Amortized cost of these marketable securities amounted to $346,681,932 and $345,122,968 as of September 30, 2022, and December 31, 2021, respectively.

A decline in the market value of held-to-maturity securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying costs to such securities’ fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent to year-end, forecasted performance of the investee, and the general market condition in the geographic area or industry the investee operates in.

Premiums and discounts are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and accretion is included in the “interest earned on investment held in trust account” line item in the statements of operations. Interest income is recognized when earned. Accretion of the discounts amounted to $1,822,347 and $952,591 for the nine and three months ended September 30, 2022, and $30,046 and $15,796 for nine and three months ended September 30, 2021.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of September 30, 2022, and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Offering Costs

The Company complies with the requirements of Accounting Standards Codification (“ASC”) 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A-”Expenses of Offering”. Offering costs consist of legal, accounting, underwriting discount and other costs that are directly related to the IPO. Accordingly, as of December 31, 2021, offering costs totaling $19,570,579, consisting of $6,900,000 in cash underwriting fees, $12,075,000 of deferred underwriting fees, and $595,579 other offering costs. Transactions costs amounting to $569,513 were allocated to the warrant liability and are recorded in general and administrative expenses in the Statement of Operations

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

for the year ended December 31, 2021, with the remainder or $19,001,066, allocated to the Class A common shares sold in the Initial Public Offering. The Company adopted the residual method to allocate the gross proceeds between Class A common stock and warrants based on their relative fair values.

Shares Subject to Possible Redemption

The Company accounts for its shares of Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of Class A common stock (including shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, shares of Class A common stock are classified as stockholders’ equity. The Company’s shares of Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, shares of Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.

All of the 34,500,000 shares of Class A common stock sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated memorandum and articles of association. In accordance with the accounting treatment for redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require shares of Class A common stock subject to redemption to be classified outside of permanent equity. Therefore, all shares of Class A common stock have been classified outside of permanent equity.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Class A common stock are affected by charges against additional paid in capital and accumulated deficit. At September 30, 2022, the Shares of Class A common stock reflected in the balance sheet are reconciled in the following table:


Gross proceeds	$	345,000,000
Less:
Redeemable ordinary share issuance costs		(18,882,781)
Proceeds allocated to Public Warrants		(10,030,530)
Excess fair value over consideration of the anchor investors investment in the sponsor		(3,946,407)

Plus:
Accretion of carrying value to redemption value		32,859,718
Class A common stock subject to possible redemption, December 31, 2021		345,000,000
Accretion of carrying value to redemption value		1,286,379
Class A common stock subject to possible redemption, September 30, 2022	$	346,286,379

Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

●	Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

●	Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

●

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are initially recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

Warrant Liability

The Company accounts for the 7,080,000 warrants issued in connection with the Initial Public Offering (the 6,900,000 Public Warrants and the 180,000 Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company classifies each warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations.

Stock Based Compensation

The transfer of the Founders Shares is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of an Initial Public Offering). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. Stock-based compensation would be recognized at the date the Initial Public Offering was considered probable in an amount equal to the number of Founders Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. The value of the transferred Founders Shares on the grant date of September 4, 2020, was minimal, as such no stock-based compensation expense has been recognized.

Income Taxes

The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company has identified the United States as its only “major” tax jurisdiction.

The Company is subject to income tax examinations by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Net Income Per Common Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income per share of Class A common stock is computed by dividing net income by the weighted average number of shares of Class A common stock, which are referred to as outstanding for the period. As of September 30, 2022, the Company had 34,500,000 Class A common public shares subject to possible redemption, 900,000 Class A common private shares and 8,625,000 Class B common shares. Earnings and losses are shared pro rata between the two classes of private shares or 9,525,000 private shares. The calculation of diluted net income (loss) per share does not consider the effect of the warrants issued in connection with the (i) IPO, (ii) exercise of over-allotment and (iii) Private Placement since the exercise of the warrants would be anti-dilutive. The warrants are exercisable to purchase 7,080,000 shares of Class A common stock in the aggregate. At September 30, 2022, the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted income per share is the same as basic income per share for the three months ended September 30, 2022, and 2021.

For the nine months ended September 30, 2022, and 2021, net income per common share is as follows:


	Nine months ended September 30, 2022				Nine months ended September 30, 2021
	(unaudited)				(unaudited)
	Public Shares		Private Shares		Public Shares		Private Shares
Basic and diluted net income per share
Numerator:
Allocation of net income	$	4,490,264	$	1,239,703	$	1,854,741	$	527,401

Denominator
Weighted-average shares outstanding		34,500,000		9,525,000		33,236,264		9,450,824
Basic and diluted net income per share	$	0.13	$	0.13	$	0.06	$	0.06


	Three months ended September 30, 2021				Three months ended September 30, 2021
	(unaudited)				(unaudited)
	Public Shares		Private Shares		Public Shares		Private Shares
Basic and diluted net income per share
Numerator:
Allocation of net income	$	928,227	$	256,272	$	2,696,156	$	744,373

Denominator
Weighted-average shares outstanding		34,500,000		9,525,000		34,500,000		9,525,000
Basic and diluted net income per share	$	0.03	$	0.03	$	0.08	$	0.08

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

Recent Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. As we are a smaller reporting company, adoption of ASU 2020-06 will be required for fiscal years beginning after December 15, 2023, including interim periods with those fiscal years. The Company is still evaluating the impact of ASU 2020-06 and will adopt as required.

The Company’s management does not believe that there are any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, that would have a material effect on the Company’s financial statements.

Note 3 — Public Offering

Pursuant to the Initial Public Offering, the Company sold 34,500,000 units at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock (such shares of Class A common stock included in the Units being offered, the “Public Shares”) and one-fifth of one redeemable warrant (each, a “Public Warrant”). Each whole Public Warrant entitles the registered holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment, at any time commencing on the later of 12 months from the closing of the Initial Public Offering or 30 days after the completion of the initial Business Combination. Only whole Public Warrants are exercisable. The Public Warrants will expire at 5:00 p.m., New York City time, on the fifth anniversary of the Company’s completion of an initial Business Combination, or earlier upon redemption or liquidation.

No Public Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of Class A Common Stock issuable upon exercise of the Public Warrants and a current prospectus relating to such shares. Notwithstanding the foregoing, if a registration statement covering the issuance of the shares issuable upon exercise of the Public Warrants is not effective within 90 days from the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement or a current prospectus, exercise Public Warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their Public Warrants on a cashless basis.

The warrants included in the Private Placement Units (the “Private Warrants”) are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants and the Class A common stock issuable upon exercise of the Private Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants will be non-redeemable so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Warrants are held by someone other than the initial stockholder or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Redemptions of warrants when the price of Class A common stock equals or exceeds $18.00. The Company may call the Public Warrants for redemption:

●

in whole and not in part;

●

at a price of $0.01 per warrant;

●

upon a minimum of 30 days’ prior written notice of redemption; and

●

if, and only if, the last reported closing price of the Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30 trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00 — Commencing ninety days after the warrants become exercisable, the Company may redeem the outstanding Public Warrants:

●

in whole and not in part;

●

at a price of $0.10 per warrant provided that holders will be able to exercise their warrants prior to redemption and receive that number of shares of Class A common stock determined based on the redemption date and the “fair market value” of the Company’s Class A common stock;

●

upon a minimum of 30 days’ prior written notice of redemption;

●

if, and only if, the last reported sale price of the Company’s Class A common stock equals or exceeds

●

$10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; and

●

if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto is available throughout the 30-day period after the written notice of redemption is given.

The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuance of shares of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrant shares. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

If (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Company’s initial stockholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the completion of such initial Business Combination (net of redemptions), and (z) the volume- weighted average trading price of the Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.

Certain funds, referred to as the Company’s “anchor investors,” expressed to the Company an interest and purchased an aggregate of approximately 6,000,000 Units in the Initial Public Offering. In connection with providing these expressions of interest, the anchor investors purchased membership interests in the Sponsor entitling them to an economic interest in certain of the Founder Shares owned by the Sponsor and in certain of the Private Placement Units purchased by the Sponsor.

Pursuant to a subscription agreement with the Sponsor, one of the anchor investors has agreed with the Sponsor that, with respect to 1,499,950 of the Units it has expressed an interest in purchasing (or all of the Units it purchased in the Proposed Public Offering, if less), such anchor investor (1) will not transfer such Units (or underlying shares of Class A common stock) prior to the date the Company completes its initial Business Combination, and (2) will not exercise its redemption rights with respect to any shares of Class A common stock included in such Units in connection with the completion of the Company’s initial Business Combination or any amendment to the provisions of the Company’s amended and restated certificate of incorporation relating to the Company’s pre-initial Business Combination activity and related stockholders’ rights. Further, each of the anchor investors has agreed with the Sponsor that if it does not purchase the maximum number of Units it has expressed an interest in purchasing, it will forfeit all of its indirect holdings of Founder Shares held within the Sponsor, and if after such purchase, it owns less than that number of units at the time of a stockholder vote in

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

connection with the Company’s initial Business Combination or on the business day immediately prior to the scheduled closing of such initial Business Combination, it will forfeit a portion of its indirect holdings of Founder Shares held within the Sponsor, and the Sponsor will have the right to redeem the anchor investor’s interest in the Sponsor related to Private Placement Units at the original purchase price. Other than such agreements with the Sponsor, the anchor investors are not required to: (1) hold any Units, shares of Class A common stock or Warrants they may have purchased in the Initial Public Offering or thereafter for any amount time, (2) vote any shares of Class A common stock they may own at the applicable time in favor of the initial Business Combination or (3) refrain from exercising their right to redeem their public shares at the time of the Company’s initial Business Combination. Pursuant to their subscription agreements with the Sponsor, the anchor investors will not be granted any material additional stockholder or other rights and will only be issued membership interests in the Sponsor with no right to control the Sponsor or vote or dispose of any Founder Shares, Private Placement Units or underlying securities (which will continue to be held by the Sponsor until following the Company’s initial Business Combination).

There can be no assurance as to the number of Units purchased in the Initial Public Offering (or underlying shares of Class of Class A common stock) the anchor investors will retain, if any, prior to or upon the consummation of the Company’s initial Business Combination. In the event that the anchor investors vote in favor of the Company’s initial Business Combination, a smaller portion of affirmative votes from other public stockholders would be required to approve the Company’s initial Business Combination.

Note 4 — Related Party Transactions

Founder Shares

On August 31, 2020, the Sponsor purchased an aggregate of 8,625,000 shares (the “Founder Shares”) of the Company’s Class B common stock, par value $0.0001, for an aggregate price of $25,000, or $.0029 per share. On September 4, 2020, the Company’s initial director nominees purchased 60,000 Founder Shares from the Sponsor for $176, or $.0029 per share. On January 11, 2021, the underwriters fully exercised their over-allotment option, such that none of the Founder Shares remain subject to forfeiture.

The initial stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the Company’s initial Business Combination, (x) if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of Class A common stock for cash, securities or other property.

Private Placement Units

The Sponsor purchased an aggregate of 900,000 Private Placement Units, at a price of $10.00 per Private Placement Unit ($9.0 million in the aggregate) in a private placement that occurred simultaneously with the closing of the Initial Public Offering. Each Private Placement Unit consists of one share of Class A common stock (such shares of Class A common stock included in the Private Placement Units, the “Private Shares”) and one-fifth of one redeemable warrant (each, a “Private Warrant”). Each Private Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 3). A portion of the proceeds from the Private Placement Units were added to proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in trust will be part of the liquidating distribution to the public stockholders, and the Private Warrants will expire worthless. The Private Warrants will be non-redeemable and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Units or the securities underlying the Private Placement Units until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

that results in all of the Company’s stockholders having the right to exchange their shares of Class A common stock for cash, securities or other property.

Related Party Loans

On August 31, 2020, the Sponsor agreed to loan the Company an aggregate of up to $200,000 to cover expenses related to the Proposed Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable on the earlier of June 30, 2021, or the completion of the Initial Public Offering. On January 11, 2021, the Company repaid $83,000 that was borrowed under the Note.

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into additional units of the post Business Combination entity at a price of $10.00 per unit. Such units would be identical to the Private Placement Units. As of September 30, 2022, and December 31, 2021, the Company had no borrowings under the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans.

Administrative Support Agreement

The Company entered into an agreement, commencing on the effective date of the Initial Public Offering through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space and general and administrative services. For the nine and three months ended September 30, 2022, and 2021, $90,000 and $30,000 and $83,550 and $30,000 has been charged to general and administrative expenses for services performed in accordance with the terms of the administrative support agreement. As of September 30, 2022, and December 31, 2021, $206,775 and $116,775 were included in accrued expenses for amounts due under the agreement.

The Sponsor, executive officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made to the Sponsor, officers, directors or their affiliates and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on the Company’s behalf.

Note 5 — Commitments

Registration Rights

The Sponsor and the Company’s executive officers, directors and director nominees and their permitted transferees will be entitled to demand that the Company register for resale the Founder Shares, the Private Placement Units and underlying securities and any securities issued upon conversion of Working Capital Loans. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s consummation of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities.

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

Underwriting Agreement

On January 11, 2021, the underwriters fully exercised their over-allotment option and were paid an underwriting discount of $0.20 per unit, or $6.9 million in the aggregate, upon the closing of the Initial Public Offering. The underwriters are entitled to a deferred fee of $0.35 per Unit, or $12,075,000 in the aggregate which is included as deferred underwriting fee payable in the accompanying balance sheet as of September 30, 2022, and December 31, 2021. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Note 6 — Stockholders’ Equity

Class A Common Stock — The Company is currently authorized to issue 200,000,000 shares of Class A common stock with a par value of $0.0001 per share. Stockholders of Class A common stock are entitled to one vote for each share. As of September 30, 2022, and 2021, there were 35,400,000 shares of Class A common stock issued and outstanding, respectively. At September 30, 2022, and December 31, 2021, 34,500,000 shares were subject to possible redemption.

Class B Common Stock — the Company is current authorized to issue 20,000,000 shares of Class B common stock with a par value of $0.0001 per share. Stockholders of Class B common stock are entitled to one vote for each share. As of September 30, 2022, and December 31, 2021, there were 8,625,000 shares of Class B common stock outstanding.

Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders except as required by law.

The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the initial Business Combination, or earlier at the option of the holder, initially on a one-for-one basis. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of the initial Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of the Class B common stock agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the total number of all shares of common stock outstanding upon completion of the Initial Public Offering (not including the shares of Class A common stock underlying the private placement units) plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the initial Business Combination (net of the number of shares of Class A common stock redeemed in connection with the initial Business Combination), excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination.

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2022, and December 31, 2021, there were no shares of preferred stock issued or outstanding.

Note 7 — Fair Value Measurements

The following table presents fair value information as of September 30, 2022, and December 31, 2021, for the Company’s warrant liability that are accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. The Company’s Private Placement Warrant liability is based on a Modified Black Scholes Model utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. The fair value of the Private Placement Warrant liability is classified within Level 3 of the fair value hierarchy. Significant deviations from these estimates and inputs could result in a material change in fair value. The Company’s warrant liability for the Public Warrants is based on unadjusted quoted prices in active markets for identical assets or liabilities that the

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

Company has the ability to access. On March 5, 2021, the Public Warrant liability was reclassified from a Level 3 to a Level 1 classification as they began to have quoted prices in active markets.


		September 30,		December 31,
Liabilities:	Level	2022		2021
Warrant Liability – Public Warrants	1	$	828,000	$	5,796,000
Warrant Liability – Private Placement Warrants	3	$	21,600	$	152,676

The warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statement of operations.

The warrants are measured at fair value on a recurring basis. Fair value as of September 30, 2022, and December 31, 2021, for the public warrants are based upon quoted market prices as Level 1 and the Modified Black Scholes Model for the private placement warrants as Level 3.

The key inputs into the Modified Black Scholes Model for the private placement warrants were as follows:




Input	September 30, 2022			December 31, 2021
Risk-free interest rate		4.02	%		1.11	%
Expected term to initial business combination (years)		0.27 years			0.47 years
Dividend yield		0	%		0	%
Expected volatility		10.18	%		17.0	%
Exercise price	$	11.50		$	11.50
Fair value of Units	$	0.12		$	0.8482

To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Because of the inherent uncertainty of valuation, those estimated values may be materially higher or lower than the values that would have been used had a ready market for the investments existed. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for investments categorized in Level 3.

The following table provides a reconciliation of changes in fair value of the beginning and ending balances for our warrants classified as Level 3:


	Private Placement
	Warrants		Public Warrants		Warrant Liability
Initial measurement of fair value on December 31, 2021	$	152,676	$	5,796,000	$	5,948,676
Change in valuation inputs or other assumptions		(113,022)		(4,278,000)		(4,391,022)
Fair value as of June 30, 2022		39,654		1,518,000		1,557,654
Change in valuation inputs or other assumptions		(18,054)		(690,000)		(708,054)
Fair value as of September 30, 2022	$	21,600	$	828,000	$	849,600

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. The Company did not identify any subsequent events that would require adjustment or disclosure in the financial statements.

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

Note 8— Income Taxes

The Company’s net deferred tax assets are as follows:


	September 30, 2022		December 31, 2021		June 30, 2022
Deferred tax asset:
Organizational costs/Startup expenses	$	632,285	$	476,100		49,828
Federal net operating loss		—		16,177		—
Total deferred tax asset		632,285		492,277		49,828
Valuation allowance		(632,285)		(492,277)		(49,828)
Deferred tax asset, net of allowance	$	—	$	—	$	—

The income tax provision consists of the following:


	Nine months ended September 30,				Three months ended September 30,
	2022		2021		2022		2021
Federal:
Current	$	344,337	$	—	$	189,691	$	—
Deferred		(156,185)		—	$	(49,828)		—

State:
Current		—		—		—		—
Deferred		—		—		—		—
Valuation allowance		156,185		—		49,828		—
Income tax provision	$	344,337	$	—	$	189,691	$	—

In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the nine months ended September 30, 2022, the change in the valuation allowance was $140,008.

A reconciliation of the federal income tax rate to the Company’s effective tax rate is as follows:


	Nine months ended September 30,			Three months ended September 30,
	2022		2021	2022		2021
Statutory federal income tax rate	21.0	%	—	21.0	%	—
State taxes, net of federal tax benefit	0.0	%	—	0.0	%	—
Change in fair value of the warrant liability	(17.6)	%	—	(10.8)	%	—
Change in valuation allowance	2.6	%	—	3.6	%	—
Income tax provision	5.9	%	—	13.8	%	—

Table of Contents

VECTOIQ ACQUISITION CORP. II

Notes to Unaudited Condensed Interim Financial Statements

Note 9 – Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. The Company identified the following subsequent event:

On October 28, 2022, the Company filed a Preliminary Proxy Statement on Schedule 14A (the “Proxy Statement”) relating to a special meeting of stockholders that is anticipated to be held in December 2022 to approve an amendment to the Company’s amended and restated certificate of incorporation (the “Charter Amendment”) which would, if implemented, allow the Company to unwind and redeem all of its outstanding public shares in advance of the mandatory liquidation date of January 11, 2023 (or April 11, 2023, if the Company has executed a letter of intent, agreement in principle or definitive agreement for an initial business combination on or before January 11, 2023). If implemented, the Charter Amendment would also allow the Company to remove the Redemption Limitation (as defined in the amended and restated certificate of incorporation) to allow the Company to redeem public shares notwithstanding the fact that such redemption would result in the Company having net tangible assets of less than $5,000,001, and to remove up to $100,000 of interest earned on the amount on deposit in the Trust Account prior to redeeming the public shares in connection with the special meeting in order to pay dissolution expenses. The Company will also seek stockholder approval to amend the Trust Agreement to change the date on which the trustee must commence liquidation of the Trust Account to the time and date immediately following the filing of the Charter Amendment with the Secretary of State of the State of Delaware.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

We are a blank check company incorporated on August 10, 2020, for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We intend to effectuate our initial business combination using cash from the proceeds of our offering and the sale of the private placement warrants, our shares, debt or a combination of cash, equity and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities from inception to September 30, 2022, were organizational activities, those necessary to prepare for the initial public offering, described below, and, after the initial public offering, identifying a target company for a business combination. We do not expect to generate any operating revenues until after the completion of our business combination. We generate non-operating income in the form of interest income on marketable securities held in the trust account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing a business combination.

For the nine months ended September 30, 2022, we had a net income of $5,729,967, which consisted of the change in the fair value of the warrant liability of $5,099,076 and interest earned on investment held in the trust account of $1,868,964 offset by general and administrative expenses of $893,736 and income tax expense of $344,337.

For the nine months ended September 30, 2021, we had a net loss of $2,382,142, which consisted of the change in the fair value of the warrant liability of $4,910,274 and interest earned on investment held in the trust account of $82,283 offset by general and administrative expenses of $2,610,415.

For the three months ended September 30, 2022, we had a net income of $1,184,499, which consisted of the change in the fair value of the warrant liability of $708,054 and interest earned on investment held in the trust account of $953,413 offset by general and administrative expenses of $287,277 and incomes taxes of $189,691.

For the three months ended September 30, 2021, we had a net income of $3,440,529, which consisted of the change in the fair value of the warrant liability of $4,166,100 and interest earned on investment held in the trust account of $15,795 offset by general and administrative expenses of $741,366.

Liquidity and Capital Resources

On January 11, 2021, we consummated our initial public offering (the “Initial Public Offering”) of 34,500,000 units (the “Units” and, with respect to the class A common stock included in the Units sold, the “Public Shares”), which included the exercise in full by the underwriters of their overallotment option in the amount of 4,500,000 Units, at $10 per unit, generating gross proceeds of $345,000,000. Simultaneously with the closing of the IPO, the Company consummated the sale, in a private placement, of 900,000 units (each, a “Private Placement Unit” and collectively, the “Private Placement Units”) to the Sponsor at a price of $10.00 per Private Placement Unit, generating total proceeds of $9,000,000.

For the nine months ended September 30, 2022, cash used in operating activities was $946,998. Net income of $5,729,967 was decreased by $5,099,076 for the change in the fair value of the warrant liability and interest earned on investment held in the trust account of $1,868,964 offset by an increase of $291,075 in net operating assets and liabilities.

We intend to use substantially all of the funds held in our trust account, including any amounts representing interest earned on the trust account (which interest shall be net of taxes payable) to complete our initial business combination. We may withdraw interest to pay our taxes. Delaware franchise tax is based on our authorized shares or on our assumed par and non-par capital, whichever yields a lower result. Under the authorized shares method, each share is taxed at a graduated rate based on the number of authorized shares with a

Table of Contents

maximum aggregate tax of $200,000 per year. We expect the interest earned on the amount in the trust account will be sufficient to pay our taxes. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

As of September 30, 2022, we had cash available to us of approximately $97,000 held outside the trust account. We will use these funds primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a business combination, and to pay taxes to the extent the interest earned on the trust account is not sufficient to pay our taxes.

In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsors or our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment.

The Company has until January 11, 2023, to consummate a Business Combination. If a Business Combination is not consummated by this date and an extension not requested by the Sponsor, there will be a mandatory liquidation and subsequent dissolution of the Company. Although the Company intends to consummate a Business Combination on or before January 11, 2023, it is uncertain that the Company will be able to consummate a Business Combination by this time. Management has determined that the mandatory liquidation, should a Business Combination not occur, and an extension is not requested by the Sponsor, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. The Company’s plan is to complete a business combination or obtain an extension on or prior to January 11, 2023, however it is uncertain that the Company will be able to consummate a Business Combination or obtain an extension by this time. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after January 11, 2023.

Since its IPO, the Company’s management has reviewed over 90 potential targets and conducted extensive due diligence for over two dozen of such targets, 14 of which received illustrative proposals and three of which received letters of intent from the Company. However, the Company has not entered into an agreement to effect a business combination with any of these potential targets for a variety of reasons, including, among other things: (i) the parties’ inability to reach an agreement on valuation; (ii) the Company’s preliminary assessment of the relevant target company’s business model, customer concentration, competitive landscape and

Table of Contents

corresponding risks to future financial performance; (iii) the Company’s preliminary assessment of the relevant target company’s ability to execute its business and financial plans and scale its business; and (iv) alternative options available to potential targets, such as pursuing a traditional IPO or waiting for the capital markets to improve before pursuing a listing. Changes in the regulatory landscape due to proposed SEC rules have further affected the Company’s prospects for consummating a business combination. In addition, on August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for among other things a new US federal 1% excise tax on certain repurchase of stock by publicly traded US domestic corporations. The excise tax is imposed on the repurchasing corporation itself, not its stockholders from which shares are repurchased. Any redemptions or other repurchases that occur after December 31, 2022 may be subject to the excise tax. As a result, the Company has determined to seek the approval of its stockholders to, among other things, complete an early unwind in 2022.

Off-Balance Sheet Financing Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the Sponsor a monthly fee of $10,000 for office space, administrative and support services, provided to the Company upon completion of our initial public offering.

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Warrant Liability

We account for the warrants issued in connection with our initial public offering in accordance with the guidance contained in ASC 815-40 under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, we classify the warrants as liabilities at their fair value and adjust the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statement of operations. The initial fair value of the public warrants was estimated using the closing public market price and the Modified Black Scholes Model for the private placement warrants.

Class A Common Stock Subject to Possible Redemption

We account for our shares of Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, Class A common stock are classified as stockholders’ equity. Our Class A common stock feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of our balance sheet.

Recent Accounting Standards

Table of Contents

815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. As we are a smaller reporting company, adoption of ASU 2020-06 will be required for fiscal years beginning after December 15, 2023, including interim periods with those fiscal years. The Company is still evaluating the impact of ASU 2020-06 and will adopt as required.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial and accounting officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a- 15(e) and 15d-15(e) under the Exchange Act) as of the end of the fiscal quarter ended September 30, 2022. Based upon this evaluation, our principal executive officer and principal financial and accounting officer have concluded that during the period covered by this Quarterly Report, our disclosure controls and procedures were not effective, due to (i) the material weakness in our internal control over financial reporting related to analyzing complex financial instruments, including warrant liabilities and redeemable Class A common stock as temporary equity, and accounting for the accretion of certain costs in computing earnings per share, previously disclosed in our quarterly report for the quarter September 30, 2021, and (ii) our failure to record an accrual relating to a contingent fee arrangement, constituting an additional material weakness. In light of these material weaknesses, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the financial statements included in this Quarterly Report on Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the periods presented.

Changes in Internal Control over Financial Reporting

Other than as described above, there was no change in our internal control over financial reporting that occurred during the quarter ended of September 30, 2022, covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in Annual Report on Form 10-K/A for the year ended December 31, 2021, filed with the SEC on April 21, 2022 (the “Annual Report”). Any of

Table of Contents

these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report, except for the following amended and restated risk factor:

Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, investments and results of operations.

We are subject to laws and regulations enacted by national, regional and local governments. In particular, we will be required to comply with certain SEC and other legal requirements. Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application also may change from time to time and those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to complete our initial business combination, and results of operations.

On March 30, 2022, the SEC issued proposed rules that would, among other items, impose additional disclosure requirements in business combination transactions involving SPACs and private operating companies; amend the financial statement requirements applicable to business combination transactions involving such companies; update and expand guidance regarding the general use of projections in SEC filings, as well as when projections are disclosed in connection with proposed business combination transactions; increase the potential liability of certain participants in proposed business combination transactions; and impact the extent to which SPACs could become subject to regulation under the Investment Company Act of 1940. These rules, if adopted, whether in the form proposed or in revised form, may materially adversely affect our business, including our ability to negotiate and complete our initial business combination and may increase the costs and time related thereto.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On January 11, 2021, we consummated the Initial Public Offering of 34,500,000 Units, inclusive of 4,500,000 Units sold to the underwriters upon the underwriters’ election to fully exercise their over-allotment option at a price of $10.00 per Unit, generating total gross proceeds of $345,000,000. Cowen and Company, LLC and Morgan Stanley acted as the joint book-running of managers the Initial Public Offering. The securities in the offering were registered under the Securities Act on registration statements on Form S-1 (No. 333-251510). The Securities and Exchange Commission declared the registration statements effective on January 6, 2021.

Simultaneous with the consummation of the Initial Public Offering, and the full exercise of the over-allotment option, we consummated the private placement of an aggregate of 900,000 Private Placement Units to the Sponsor at a price of $10.00 per Private Placement Unit, generating total proceeds of $9,000,000. The issuance was made pursuant to the exemption from registration contained in Section 4(a) (2) of the Securities Act.

Of the gross proceeds received from the Initial Public Offering including the over-allotment option, and the sale of the Private Placement Warrants, $345,000,000 was placed in the Trust Account.

We paid a total of $6,900,000 in underwriting discounts and commissions and $641,726 for other costs and expenses related to the Initial Public Offering. In addition, the underwriters agreed to defer up to $12,075,000 in underwriting discounts and commissions.

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not Applicable.

Table of Contents

Item 5. Other Information.

On August 9, 2022, Sherwin Prior provided notice of his resignation as a member of the board of directors of the Company, to be effective as of August 20, 2022. Mr. Prior’s resignation was not the result of any dispute or disagreement with the Company. Upon Mr. Prior’s resignation, Richard Lynch will be appointed to the audit committee of the board to replace Mr. Prior, and Marc Sulam, a current member of the audit committee, will replace Mr. Prior as chair of the committee.

Table of Contents

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.


No.		Description of Exhibit
3.1		Amended and Restated Certificate of Incorporation of the Company. ⁽¹⁾
4.1		Warrant Agreement, dated January 6, 2021, between the Company and Continental Stock Transfer & Trust Company. ⁽¹⁾
10.1		Letter Agreement, dated January 6, 2021, among the Company, VectoIQ Holdings II, LLC and each of the executive officers, directors and director nominees of the Company. ⁽¹⁾
10.2		Investment Management Trust Agreement, dated January 6, 2021, between the Company and Continental Stock Transfer & Trust Company. ⁽¹⁾
10.3		Registration Rights Agreement, dated January 6, 2021, among the Company and certain securityholders. ⁽¹⁾
10.4		Unit Subscription Agreement, dated January 6, 2021, between the Company and VectoIQ Holdings II, LLC.⁽¹⁾
10.5		Form of Indemnity Agreement. ⁽²⁾
10.6		Underwriting Agreement, dated January 6, 2021, between the Company and Cowen and Company, LLC. ⁽¹⁾
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		Inline XBRL Instance Document
101.SCH*		Inline XBRL Taxonomy Extension Schema Document
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Date File, formatted in Inline XBRL (contained in Exhibit 101)

*Filed herewith.

**Furnished.

(1)	Previously filed as an exhibit to our Current Report on Form 8-K filed on January 12, 2021 and incorporated by reference herein.

(2)	Previously filed as an exhibit to our Registration Statement on Form S-1 (File No. 333-251510), filed with the SEC on December 29, 2020, and incorporated by reference herein.

Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	VECTOIQ ACQUISITION CORP. II

Date: November 2, 2022	By:	/s/ Stephen Girsky
	Name:	Stephen Girsky
	Title:	Chief Executive Officer
		(Principal Executive Officer)

Date: November 2, 2022	By:	/s/ Steve Shindler
	Name:	Steve Shindler
	Title:	Chief Financial Officer
		(Principal Accounting Officer and Financial Officer)

VectoIQ Acquisition Corp. II 10-Q